ENLV

NASDAQ HEALTHCARE

Enlivex Therapeutics Ltd

$0.88

$0.02 (+2.11%)

Live quote

52w: $0.86 – $27.15

Loading chart…

P/E Ratio0.17

P/B Ratio0.11

EV/EBITDA—

Debt/Equity—

ROE63.85%

ROIC—

Revenue Growth—

Gross Margin—

Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel.

Create a free account to add ENLV to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.